Strategic Direction

Melanoma study finds new way to enhance targeted therapies

With the help of a drug formerly used to treat HIV/AIDS, researchers at Vanderbilt University Medical Center (VUMC) have found a way to make melanoma cells more vulnerable to targeted anti-cancer therapy.

UDN program dedicated to solving medical mysteries

It’s human nature to need answers. Patients with debilitating symptoms need a diagnosis — somewhere to place the blame, a starting point to search for answers.

First class of PM&R residents sets bar high for new program

The inaugural class of the Physical Medicine and Rehabilitation residency program is making a big impact on patient care and research at Vanderbilt University Medical Center (VUMC).

Protocol standardizes care for pregnant women on opiates

Complications related to opioid abuse occur in 54,000 pregnancies annually in the United States, and Tennessee ranks among the top 10 states in the number of opioid-dependent pregnant women.

Team isolates new antibodies that may aid RSV vaccine design

Researchers at Vanderbilt University Medical Center (VUMC) have taken another step toward developing a vaccine against respiratory syncytial virus (RSV), the major cause of life-threatening pneumonia in infants worldwide.

New management software bolsters research cores

This month the Office of Research at Vanderbilt University Medical Center (VUMC) began transitioning VUMC research cores, facilities and shared resources (known collectively as “cores”) to a new core management application that officials said will streamline ordering and billing for core services.

1 2